HC ANDERSEN CAPITAL

Ascelia Pharma – First quarter 2025 highlights

Name: Ascelia Pharma - First quarter 2025 highlights
Start: 2025-05-19T10:00:00+0200
End: 2025-05-19T10:30:00+0200

AUTHOR

KathrineWolf

DATE

23. April 2025

Ascelia Pharma – First quarter 2025 highlights

Ascelia Pharma - First quarter 2025 highlights 19 MayMay 2025 10:00 - 10:30

Information

Ascelia Pharma - First quarter 2025 highlights 19 MayMay 2025 10:00 - 10:30

Ascelia Pharma - First quarter 2025 highlights

Impero – Præsentation af Q1 2025

AKTIER MED FRIIS – UGE 19 2025

Explore our services

INFORMATION

Bredgade 23B 2. sal
1260 København K
View on map
Phone: 28 74 66 40
CVR: 41474793

About

What we do

HC Andersen Capital was established in 2020 and is at the forefront of digital Investor Relations, amplifying market presence.

Our tailored services encompass IR and ESG advisory, Legal Support, cutting-edge digital solutions such as IR websites and IR distribution software, Commissioned Research, Corporate Finance advisory and more. We are proudly Certified Advisor on Nasdaq First North Copenhagen.

About us

What we do in short

Advisory

IR Services

Our Community

Ascelia Pharma – First quarter 2025 highlights

Ascelia Pharma – First quarter 2025 highlights

Information

Explore our services

INFORMATION

About

What we do

2024 - HC Andersen Capital